CN111499551A - Preparation method of β-hydroxyl-substituted alkyl dithiocarbamate - Google Patents
Preparation method of β-hydroxyl-substituted alkyl dithiocarbamate Download PDFInfo
- Publication number
- CN111499551A CN111499551A CN202010382653.6A CN202010382653A CN111499551A CN 111499551 A CN111499551 A CN 111499551A CN 202010382653 A CN202010382653 A CN 202010382653A CN 111499551 A CN111499551 A CN 111499551A
- Authority
- CN
- China
- Prior art keywords
- preparation
- substituted alkyl
- hydroxyl
- alkyl dithiocarbamate
- mmol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 37
- 239000012990 dithiocarbamate Substances 0.000 title claims abstract description 18
- 238000006243 chemical reaction Methods 0.000 claims abstract description 62
- 239000003960 organic solvent Substances 0.000 claims abstract description 11
- CSNJTIWCTNEOSW-UHFFFAOYSA-N carbamothioylsulfanyl carbamodithioate Chemical compound NC(=S)SSC(N)=S CSNJTIWCTNEOSW-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000003054 catalyst Substances 0.000 claims abstract description 10
- 239000003513 alkali Substances 0.000 claims abstract description 4
- 238000001816 cooling Methods 0.000 claims abstract description 4
- 125000003011 styrenyl group Chemical class [H]\C(*)=C(/[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims abstract 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 63
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 42
- 239000012141 concentrate Substances 0.000 claims description 40
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 claims description 25
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical group C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 24
- 239000003208 petroleum Substances 0.000 claims description 21
- 239000002904 solvent Substances 0.000 claims description 21
- 238000004809 thin layer chromatography Methods 0.000 claims description 21
- 229960002447 thiram Drugs 0.000 claims description 13
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 claims description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 12
- KUAZQDVKQLNFPE-UHFFFAOYSA-N thiram Chemical group CN(C)C(=S)SSC(=S)N(C)C KUAZQDVKQLNFPE-UHFFFAOYSA-N 0.000 claims description 12
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Natural products C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims description 10
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 8
- PGAXJQVAHDTGBB-UHFFFAOYSA-N dibutylcarbamothioylsulfanyl n,n-dibutylcarbamodithioate Chemical compound CCCCN(CCCC)C(=S)SSC(=S)N(CCCC)CCCC PGAXJQVAHDTGBB-UHFFFAOYSA-N 0.000 claims description 8
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 claims description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 8
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 claims description 8
- 150000003440 styrenes Chemical class 0.000 claims description 8
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims description 8
- KQJQPCJDKBKSLV-UHFFFAOYSA-N 1-bromo-3-ethenylbenzene Chemical compound BrC1=CC=CC(C=C)=C1 KQJQPCJDKBKSLV-UHFFFAOYSA-N 0.000 claims description 7
- BOVQCIDBZXNFEJ-UHFFFAOYSA-N 1-chloro-3-ethenylbenzene Chemical compound ClC1=CC=CC(C=C)=C1 BOVQCIDBZXNFEJ-UHFFFAOYSA-N 0.000 claims description 6
- JWVTWJNGILGLAT-UHFFFAOYSA-N 1-ethenyl-4-fluorobenzene Chemical compound FC1=CC=C(C=C)C=C1 JWVTWJNGILGLAT-UHFFFAOYSA-N 0.000 claims description 6
- WGGLDBIZIQMEGH-UHFFFAOYSA-N 1-bromo-4-ethenylbenzene Chemical compound BrC1=CC=C(C=C)C=C1 WGGLDBIZIQMEGH-UHFFFAOYSA-N 0.000 claims description 5
- 239000002585 base Substances 0.000 claims description 5
- UAJRSHJHFRVGMG-UHFFFAOYSA-N 1-ethenyl-4-methoxybenzene Chemical compound COC1=CC=C(C=C)C=C1 UAJRSHJHFRVGMG-UHFFFAOYSA-N 0.000 claims description 4
- QEDJMOONZLUIMC-UHFFFAOYSA-N 1-tert-butyl-4-ethenylbenzene Chemical compound CC(C)(C)C1=CC=C(C=C)C=C1 QEDJMOONZLUIMC-UHFFFAOYSA-N 0.000 claims description 4
- QUAMMXIRDIIGDJ-UHFFFAOYSA-N 5-ethenyl-4-methyl-1,3-thiazole Chemical compound CC=1N=CSC=1C=C QUAMMXIRDIIGDJ-UHFFFAOYSA-N 0.000 claims description 4
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 claims description 4
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 4
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 4
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 4
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical group [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 claims description 4
- 229910000024 caesium carbonate Inorganic materials 0.000 claims description 4
- JILPJDVXYVTZDQ-UHFFFAOYSA-N lithium methoxide Chemical compound [Li+].[O-]C JILPJDVXYVTZDQ-UHFFFAOYSA-N 0.000 claims description 4
- LZWQNOHZMQIFBX-UHFFFAOYSA-N lithium;2-methylpropan-2-olate Chemical compound [Li+].CC(C)(C)[O-] LZWQNOHZMQIFBX-UHFFFAOYSA-N 0.000 claims description 4
- AUHZEENZYGFFBQ-UHFFFAOYSA-N mesitylene Substances CC1=CC(C)=CC(C)=C1 AUHZEENZYGFFBQ-UHFFFAOYSA-N 0.000 claims description 4
- 125000001827 mesitylenyl group Chemical group [H]C1=C(C(*)=C(C([H])=C1C([H])([H])[H])C([H])([H])[H])C([H])([H])[H] 0.000 claims description 4
- 235000011056 potassium acetate Nutrition 0.000 claims description 4
- 239000011736 potassium bicarbonate Substances 0.000 claims description 4
- 229910000028 potassium bicarbonate Inorganic materials 0.000 claims description 4
- 235000015497 potassium bicarbonate Nutrition 0.000 claims description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 4
- 235000011181 potassium carbonates Nutrition 0.000 claims description 4
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 claims description 4
- 229910000160 potassium phosphate Inorganic materials 0.000 claims description 4
- 235000011009 potassium phosphates Nutrition 0.000 claims description 4
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 claims description 4
- 239000001632 sodium acetate Substances 0.000 claims description 4
- 235000017281 sodium acetate Nutrition 0.000 claims description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 4
- 235000017550 sodium carbonate Nutrition 0.000 claims description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 4
- 239000008096 xylene Substances 0.000 claims description 4
- JLBJTVDPSNHSKJ-UHFFFAOYSA-N 4-Methylstyrene Chemical compound CC1=CC=C(C=C)C=C1 JLBJTVDPSNHSKJ-UHFFFAOYSA-N 0.000 claims description 3
- 238000000746 purification Methods 0.000 claims description 2
- 238000000926 separation method Methods 0.000 claims description 2
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 claims 1
- ROLKQUDZUWUVJB-UHFFFAOYSA-N chlorobenzene;ethene Chemical group C=C.ClC1=CC=CC=C1 ROLKQUDZUWUVJB-UHFFFAOYSA-N 0.000 claims 1
- 238000003786 synthesis reaction Methods 0.000 abstract description 7
- 239000012295 chemical reaction liquid Substances 0.000 abstract 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 76
- 239000000203 mixture Substances 0.000 description 38
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 19
- 238000005160 1H NMR spectroscopy Methods 0.000 description 19
- 238000005481 NMR spectroscopy Methods 0.000 description 19
- -1 thiuram disulfides Chemical class 0.000 description 19
- 239000011734 sodium Substances 0.000 description 16
- AUZONCFQVSMFAP-UHFFFAOYSA-N disulfiram Chemical compound CCN(CC)C(=S)SSC(=S)N(CC)CC AUZONCFQVSMFAP-UHFFFAOYSA-N 0.000 description 10
- KTZVZZJJVJQZHV-UHFFFAOYSA-N 1-chloro-4-ethenylbenzene Chemical compound ClC1=CC=C(C=C)C=C1 KTZVZZJJVJQZHV-UHFFFAOYSA-N 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- 150000001336 alkenes Chemical class 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 125000000524 functional group Chemical group 0.000 description 3
- 239000012988 Dithioester Substances 0.000 description 2
- 238000005580 one pot reaction Methods 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical class NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- DWLVWMUCHSLGSU-UHFFFAOYSA-M n,n-dimethylcarbamate Chemical compound CN(C)C([O-])=O DWLVWMUCHSLGSU-UHFFFAOYSA-M 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000010092 rubber production Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- 238000004073 vulcanization Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C333/00—Derivatives of thiocarbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C333/14—Dithiocarbamic acids; Derivatives thereof
- C07C333/18—Esters of dithiocarbamic acids
- C07C333/20—Esters of dithiocarbamic acids having nitrogen atoms of dithiocarbamate groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/26—Radicals substituted by sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
技术领域technical field
本发明涉及有机合成技术领域,具体涉及一种β-羟基取代烷基二硫代氨基甲酸酯的制备方法。The invention relates to the technical field of organic synthesis, in particular to a preparation method of a β-hydroxyl-substituted alkyl dithiocarbamate.
背景技术Background technique
在过去十年中,过渡金属催化的烯烃双官能化是将两个官能团通过一步反应引入烯烃的有效方法,具有效率高、区域选择性和立体选择性好以及对官能团的耐受性强等优点。但是,过渡金属的使用可能会引起产品的潜在污染,这在制药行业中尤其重要。Over the past decade, transition metal-catalyzed difunctionalization of alkenes has been an effective method to introduce two functional groups into alkenes through a one-step reaction, with the advantages of high efficiency, good regio- and stereoselectivity, and strong tolerance to functional groups . However, the use of transition metals can lead to potential contamination of the product, which is especially important in the pharmaceutical industry.
针对上述技术问题,近年来,提出了一种无过渡金属的合成方法。无过渡金属的合成方法尽管已经获得了烯烃选择性双官能化的众多合成结果,但通过秋兰姆二硫化物和苯乙烯的区域选择性双官能化反应,合成β-羟基取代烷基二硫代氨基甲酸酯的方法迄今为止尚未描述。主要原因可能是由于缺乏有效的方法。反应的产物为β-羟基取代烷基二硫代氨基甲酸酯,该产物是一类应用广泛的有机合成中间体,其在医药生产、有机合成及橡胶生产领域中具有重要的应用价值。In view of the above technical problems, in recent years, a transition metal-free synthesis method has been proposed. Transition-Metal-Free Synthesis Although numerous synthetic results for the selective difunctionalization of olefins have been obtained, the synthesis of β-hydroxy-substituted alkyl disulfides is achieved through the regioselective difunctionalization of thiuram disulfides and styrene. A method for substitution of carbamates has not been described so far. The main reason may be due to the lack of effective methods. The product of the reaction is β-hydroxy-substituted alkyl dithiocarbamate, which is a kind of widely used organic synthesis intermediate, and has important application value in the fields of pharmaceutical production, organic synthesis and rubber production.
发明内容SUMMARY OF THE INVENTION
本发明的目的在于提供一种β-羟基取代烷基二硫代氨基甲酸酯的制备方法,该制备方法通过秋兰姆二硫化物和苯乙烯的区域选择性双官能化反应合成β-羟基取代烷基二硫代氨基甲酸酯。The object of the present invention is to provide a preparation method of β-hydroxyl-substituted alkyl dithiocarbamate, the preparation method synthesizes β-hydroxyl through the regioselective bifunctionalization reaction of thiuram disulfide and styrene Substituted alkyl dithiocarbamates.
为实现上述目的,本发明的β-羟基取代烷基二硫代氨基甲酸酯的制备方法所采用的技术方案是:所述β-羟基取代烷基二硫代氨基甲酸酯的制备方法,包括以下步骤:In order to achieve the above object, the technical scheme adopted in the preparation method of the β-hydroxyl-substituted alkyl dithiocarbamate of the present invention is: the preparation method of the β-hydroxyl-substituted alkyl dithiocarbamate, Include the following steps:
(1)将碱催化剂、苯乙烯衍生物和二硫化秋兰姆加入有机溶剂中进行反应,然后冷却至室温,得到反应液;(1) adding alkali catalyst, styrene derivative and thiuram disulfide into an organic solvent for reaction, and then cooling to room temperature to obtain a reaction solution;
(2)将步骤(1)所得到的反应液进行浓缩,分离纯化,即得β-羟基二硫代氨基甲酸酯。(2) The reaction solution obtained in step (1) is concentrated, separated and purified to obtain β-hydroxydithiocarbamate.
进一步地,所述碱催化剂、苯乙烯衍生物、二硫化秋兰姆的摩尔比为0.2 : 0.2 :0.1。Further, the molar ratio of the base catalyst, the styrene derivative and the thiuram disulfide is 0.2: 0.2: 0.1.
进一步地,所述碱催化剂为碳酸铯、碳酸钠、碳酸钾、碳酸氢钾、磷酸钾、碳酸氢钠、醋酸钾、醋酸钠、乙醇钠、甲醇锂、叔丁醇锂、叔丁醇钾、叔丁醇钠、氢氧化锂、氢氧化钠、氢氧化钾中的一种或几种。Further, the base catalyst is cesium carbonate, sodium carbonate, potassium carbonate, potassium bicarbonate, potassium phosphate, sodium bicarbonate, potassium acetate, sodium acetate, sodium ethoxide, lithium methoxide, lithium tert-butoxide, potassium tert-butoxide, One or more of sodium tert-butoxide, lithium hydroxide, sodium hydroxide and potassium hydroxide.
进一步地,所述苯乙烯衍生物为苯乙烯、3-氯苯乙烯、4-氯苯乙烯、3-溴苯乙烯、4-溴苯乙烯、4-氟苯乙烯、4-甲基苯乙烯、4-甲氧基苯乙烯、4-叔丁基苯乙烯或4-甲基-5-乙烯基噻唑。Further, the styrene derivatives are styrene, 3-chlorostyrene, 4-chlorostyrene, 3-bromostyrene, 4-bromostyrene, 4-fluorostyrene, 4-methylstyrene, 4-methoxystyrene, 4-tert-butylstyrene or 4-methyl-5-vinylthiazole.
进一步地,所述二硫化秋兰姆为二硫化四甲基秋兰姆、二硫化四乙基秋兰姆、二硫化四丁基秋兰姆中的一种或几种。Further, the thiuram disulfide is one or more of tetramethylthiuram disulfide, tetraethylthiuram disulfide, and tetrabutylthiuram disulfide.
进一步地,所述有机溶剂为1.4-二氧六环、甲苯、二甲苯、均三甲苯、四氢呋喃、乙腈、乙醇、叔丁基甲基醚中的一种或几种。Further, the organic solvent is one or more of 1.4-dioxane, toluene, xylene, mesitylene, tetrahydrofuran, acetonitrile, ethanol, and tert-butyl methyl ether.
进一步地,所述有机溶剂的用量为:每摩尔二硫化秋兰姆用10 L有机溶剂Further, the consumption of described organic solvent is: every mole of thiuram disulfide uses 10 L of organic solvent
进一步地,所述步骤(1)中的反应温度为80℃,反应时间为48h。Further, the reaction temperature in the step (1) is 80°C, and the reaction time is 48h.
进一步地,所述步骤(2)中所述分离纯化具体步骤为:将反应液浓缩后产生的浓缩物以石油醚/乙酸乙酯体积比 5/ 1为展开剂,进行薄层色谱分离。Further, the specific steps of separation and purification in the step (2) are as follows: the concentrate produced after concentrating the reaction solution is separated by thin-layer chromatography using petroleum ether/ethyl acetate volume ratio 5/1 as a developing solvent.
本发明的β-羟基取代烷基二硫代氨基甲酸酯的制备方法,反应原理如下(以4-氯苯乙烯为例):The preparation method of β-hydroxyl-substituted alkyl dithiocarbamate of the present invention, the reaction principle is as follows (taking 4-chlorostyrene as an example):
本发明的有益效果:Beneficial effects of the present invention:
(1)本发明采用一锅煮的方法,以乙醇钠为催化剂,以经济易得的4-氯苯乙烯和二硫化四甲基秋兰姆为原料,在空气中直接发生偶联反应生成相应的2-(4-氯苯基)-2-羟乙基二甲基氨基二硫代酸酯,产物2-(4-氯苯基)-2-羟乙基二甲基氨基二硫代酸酯可作为抗菌剂、抗癌剂、硫化促进剂等;(1) The present invention adopts the method of one-pot cooking, uses sodium ethoxide as a catalyst, and uses economical and easily available 4-chlorostyrene and tetramethylthiuram disulfide as raw materials, and a coupling reaction directly occurs in the air to generate the corresponding 2 -(4-Chlorophenyl)-2-hydroxyethyldimethylaminodithioate, the product 2-(4-chlorophenyl)-2-hydroxyethyldimethylaminodithioate can be As antibacterial agent, anticancer agent, vulcanization accelerator, etc.;
(2)本发明合成体系适用范围较广,兼容卤代、烷基和烷氧基等官能团。(2) The synthesis system of the present invention has a wide application range and is compatible with functional groups such as halogenated, alkyl and alkoxy.
(3)本发明制备方法工艺简单,操作方便,反应条件温和,底物范围较广,具有较高的产率,适合推广应用。(3) The preparation method of the present invention has the advantages of simple process, convenient operation, mild reaction conditions, wide substrate range and high yield, and is suitable for popularization and application.
具体实施方式Detailed ways
下面结合具体实施例对本发明作进一步说明。The present invention will be further described below in conjunction with specific embodiments.
实施例1Example 1
2-(4-氯苯基)-2-羟乙基二甲基氨基二硫代酸酯的制备方法,包括以下步骤:The preparation method of 2-(4-chlorophenyl)-2-hydroxyethyl dimethylamino dithioate comprises the following steps:
(1)取4-氯苯乙烯0.2mmol、二硫化四甲基秋兰姆0.1mmol和乙醇钠0.2 mmol,加入1ml的1.4-二氧六环,得到混合物,将该混合物置于5ml的Schlenk管内,置于80℃的油浴中加热,反应48h后,冷却至室温,得到反应液;(1) Take 0.2 mmol of 4-chlorostyrene, 0.1 mmol of tetramethylthiuram disulfide and 0.2 mmol of sodium ethoxide, add 1 ml of 1.4-dioxane to obtain a mixture, and place the mixture in a 5 ml Schlenk tube , heated in an oil bath at 80°C, reacted for 48h, cooled to room temperature to obtain a reaction solution;
(2)将步骤(1)所得到的反应液直接进行浓缩得浓缩物,将浓缩物以乙酸乙酯/石油醚=1/5(v/v)为展开剂,进行薄层色谱分离,得15.8mg目标产物。(2) The reaction solution obtained in step (1) is directly concentrated to obtain a concentrate, and the concentrate is separated by thin layer chromatography with ethyl acetate/petroleum ether=1/5 (v/v) as a developing solvent to obtain 15.8 mg of the desired product.
本实施例的目标产品收率为58%。The target product yield of this embodiment is 58%.
对目标产品进行核磁表征,如下:1H NMR (400 MHz, CDCl3) ppm: 7.46-7.39(d, J = 8.4 Hz, 2H), 7.36-7.31 (d, J = 8.5 Hz, 2H), 5.09-4.98 (d, J = 8.4 Hz,1H), 3.90-3.79 (dd, J = 14.5, 3.4 Hz, 1H), 3.59 (s, 3H), 3.58-3.50 (t, J =14.5, 6.0 Hz, 1H), 3.42 (s, 3H), 3.28-3.18 (d, J = 2.6 Hz, 1H); 13C NMR (100MHz, CDCl3)197.4, 141.4, 133.5, 128.6, 127.3, 72.6, 45.9, 45.6, 41.8; IR(KBr): 3394, 3183, 2920, 2849, 1646, 1492, 1471, 1375, 1252, 1144, 1087, 976cm-1; HRMS (ESI) calcd. for C11H14ClNOS2: [M+Na]+: 298.0103, found: 298.0103.The target product was characterized by NMR as follows: 1H NMR (400 MHz, CDCl3) ppm: 7.46-7.39(d, J = 8.4 Hz, 2H), 7.36-7.31 (d, J = 8.5 Hz, 2H), 5.09-4.98 (d, J = 8.4 Hz, 1H), 3.90-3.79 (dd, J = 14.5, 3.4 Hz, 1H), 3.59 (s, 3H), 3.58-3.50 (t, J =14.5, 6.0 Hz, 1H), 3.42 (s, 3H), 3.28-3.18 (d, J = 2.6 Hz, 1H); 13C NMR (100MHz, CDCl3) 197.4, 141.4, 133.5, 128.6, 127.3, 72.6, 45.9, 45.6, 41.8; IR(KBr) : 3394, 3183, 2920, 2849, 1646, 1492, 1471, 1375, 1252, 1144, 1087, 976cm-1; HRMS (ESI) calcd. for C11H14ClNOS2: [M+Na]+: 298.0103, found: 298.0103.
实施例2Example 2
2-(3-氯苯基)-2-羟乙基二甲基氨基二硫代酸酯的制备方法,包括以下步骤:The preparation method of 2-(3-chlorophenyl)-2-hydroxyethyl dimethylamino dithioate, comprises the following steps:
(1)取3-氯苯乙烯0.2mmol、二硫化四甲基秋兰姆0.1mmol和乙醇钠0.2mmol,加入1ml的1.4-二氧六环,得到混合物,将该混合物置于5ml的Schlenk管内,置于80℃的油浴中加热,反应48h后,冷却至室温,得到反应液;(1) Take 0.2 mmol of 3-chlorostyrene, 0.1 mmol of tetramethylthiuram disulfide and 0.2 mmol of sodium ethoxide, add 1 ml of 1.4-dioxane to obtain a mixture, and place the mixture in a 5 ml Schlenk tube , heated in an oil bath at 80°C, reacted for 48h, cooled to room temperature to obtain a reaction solution;
(2)将步骤(1)所得到的反应液直接进行浓缩得浓缩物,将浓缩物以乙酸乙酯/石油醚=1/5(v/v)为展开剂,进行薄层色谱分离,得14.4mg目标产物。(2) The reaction solution obtained in step (1) is directly concentrated to obtain a concentrate, and the concentrate is separated by thin layer chromatography with ethyl acetate/petroleum ether=1/5 (v/v) as a developing solvent to obtain 14.4 mg of the desired product.
本实施例的目标产品收率为52%。The target product yield of this embodiment is 52%.
对目标产品进行核磁表征,如下:1H NMR (400 MHz, CDCl3) ppm: 7.49 (s,1H), 7.39-7.34 (d, J = 7.3 Hz, 1H), 7.34-7.29 (d, J = 7.8 Hz, 1H), 7.29-7.24(m, 1H), 5.08-4.98 (dd, J = 8.4, 2.6 Hz, 1H), 3.91-3.81 (dd, J = 14.6, 3.4Hz, 1H), 3.59 (s, 3H), 3.58-3.50 (dd, J = 14.6, 6.0 Hz, 1H), 3.43 (s, 3H),3.35-3.25 (d, J = 4.4 Hz, 1H); 13C NMR (100 MHz, CDCl3) 197.4, 145.0, 134.4,129.8, 127.9, 126.0, 124.1, 72.7, 45.9, 45.5, 41.8; IR(KBr): 3203, 2921,2850, 1646, 1498, 1473, 1429, 1377, 1254, 1058, 972, 527 cm-1; HRMS (ESI)calcd. for C11H14ClNOS2: [M+Na]+: 298.0103, found: 298.0102.The target product was characterized by NMR as follows: 1H NMR (400 MHz, CDCl3) ppm: 7.49 (s,1H), 7.39-7.34 (d, J = 7.3 Hz, 1H), 7.34-7.29 (d, J = 7.8 Hz , 1H), 7.29-7.24(m, 1H), 5.08-4.98 (dd, J = 8.4, 2.6 Hz, 1H), 3.91-3.81 (dd, J = 14.6, 3.4Hz, 1H), 3.59 (s, 3H) ), 3.58-3.50 (dd, J = 14.6, 6.0 Hz, 1H), 3.43 (s, 3H), 3.35-3.25 (d, J = 4.4 Hz, 1H); 13C NMR (100 MHz, CDCl3) 197.4, 145.0 , 134.4, 129.8, 127.9, 126.0, 124.1, 72.7, 45.9, 45.5, 41.8; IR(KBr): 3203, 2921, 2850, 1646, 1498, 1473, 1429, 1377, 1254, 27 cm-1058, 97 ; HRMS (ESI)calcd. for C11H14ClNOS2: [M+Na]+: 298.0103, found: 298.0102.
实施例3Example 3
2-(4-溴苯基)-2-羟乙基二甲基氨基二硫代酸酯的制备方法,包括以下步骤:The preparation method of 2-(4-bromophenyl)-2-hydroxyethyl dimethylamino dithioate, comprises the following steps:
(1)取4-溴苯乙烯0.4mmol、二硫化四甲基秋兰姆0.2mmol和乙醇钠0.4mmol,加入1 ml的1.4-二氧六环,得到混合物,将该混合物置于5ml的Schlenk管内,置于80℃的油浴中加热,反应48h后,冷却至室温,得到反应液;(1) Take 0.4 mmol of 4-bromostyrene, 0.2 mmol of tetramethylthiuram disulfide and 0.4 mmol of sodium ethoxide, add 1 ml of 1.4-dioxane to obtain a mixture, put the mixture in 5 ml of Schlenk In the tube, it was heated in an oil bath at 80°C, and after 48 hours of reaction, it was cooled to room temperature to obtain a reaction solution;
(2)将步骤(1)所得到的反应液直接进行浓缩得浓缩物,将浓缩物以乙酸乙酯/石油醚=1/5(v/v)为展开剂,进行薄层色谱分离,得17.3 mg目标产物。(2) The reaction solution obtained in step (1) is directly concentrated to obtain a concentrate, and the concentrate is separated by thin layer chromatography with ethyl acetate/petroleum ether=1/5 (v/v) as a developing solvent to obtain 17.3 mg of target product.
本实施例的目标产品收率为54%。The target product yield of this embodiment is 54%.
对目标产品进行核磁表征,如下:1H NMR (400 MHz, CDCl3) ppm: 7.54-7.45(d, J = 8.4 Hz, 2H), 7.41-7.32 (d, J = 8.3 Hz, 2H), 5.10-4.96 (dd, J = 8.4,3.0 Hz, 1H), 3.90-3.79 (dd, J = 14.5, 3.5 Hz, 1H), 3.59 (s, 3H), 3.58-3.48(m, 1H), 3.42 (s, 3H), 3.24 (s, 1H); 13C NMR (100 MHz, CDCl3)197.4, 141.9,131.6, 127.6, 121.6, 72.6, 45.9, 45.6, 41.8; IR(KBr): 3392, 2922, 2850, 2367,2333, 1906, 1646, 1590, 1488, 1375, 1252, 1143, 1064, 1008, 976 cm-1; HRMS(ESI) calcd. for C11H14BrNOS2: [M+Na]+: 341.9598, found: 341.9596.The target product was characterized by NMR as follows: 1H NMR (400 MHz, CDCl3) ppm: 7.54-7.45(d, J = 8.4 Hz, 2H), 7.41-7.32 (d, J = 8.3 Hz, 2H), 5.10-4.96 (dd, J = 8.4, 3.0 Hz, 1H), 3.90-3.79 (dd, J = 14.5, 3.5 Hz, 1H), 3.59 (s, 3H), 3.58-3.48(m, 1H), 3.42 (s, 3H) ), 3.24 (s, 1H); 13C NMR (100 MHz, CDCl3) 197.4, 141.9, 131.6, 127.6, 121.6, 72.6, 45.9, 45.6, 41.8; IR(KBr): 3392, 2922, 2850, 2367, 2333, 1906, 1646, 1590, 1488, 1375, 1252, 1143, 1064, 1008, 976 cm-1; HRMS(ESI) calcd. for C11H14BrNOS2: [M+Na]+: 341.9598, found: 341.9596.
实施例4Example 4
2-(3-溴苯基)-2-羟乙基二甲基氨基二硫代酸酯的制备方法,包括以下步骤:The preparation method of 2-(3-bromophenyl)-2-hydroxyethyl dimethylamino dithioester, comprises the following steps:
(1)取3-溴苯乙烯0.2mmol、二硫化四甲基秋兰姆0.1mmol和乙醇钠0.2mmol,加入1 ml的1.4-二氧六环混合物,将该混合物置于5 ml的Schlenk管内,置于80℃的油浴中加热,反应48h后,冷却至室温,得到反应液;(1) Take 0.2 mmol of 3-bromostyrene, 0.1 mmol of tetramethylthiuram disulfide and 0.2 mmol of sodium ethoxide, add 1 ml of 1.4-dioxane mixture, and place the mixture in a 5 ml Schlenk tube , heated in an oil bath at 80°C, reacted for 48h, cooled to room temperature to obtain a reaction solution;
(2)将步骤(1)所得到的反应液直接进行浓缩得浓缩物,将浓缩物以乙酸乙酯/石油醚=1/5(v/v)为展开剂,进行薄层色谱分离,得15.3mg目标产物。(2) The reaction solution obtained in step (1) is directly concentrated to obtain a concentrate, and the concentrate is separated by thin layer chromatography with ethyl acetate/petroleum ether=1/5 (v/v) as a developing solvent to obtain 15.3 mg of the desired product.
本实施例的目标产品收率为48%。The target product yield of this embodiment is 48%.
对目标产品进行核磁表征,如下:1H NMR (400 MHz, CDCl3) ppm: 7.64 (s,1H), 7.46-7.36 (t, J = 15.3, 7.7 Hz, 2H), 7.28-7.20 (t, J = 15.8, 8.0 Hz,2H), 5.08-4.98 (dd, J = 8.5, 3.2 Hz, 1H), 3.91-3.81 (dd, J = 14.6, 3.4 Hz,1H), 3.59 (s, 3H), 3.58-3.50 (dd, J = 14.6, 6.0 Hz, 1H), 3.43 (s, 3H), 3.29(s, 1H); 13C NMR (100 MHz, CDCl3) 197.3, 145.2, 130.8, 130.0, 129.0, 124.6,122.6, 72.6, 45.9, 45.5, 41.8; IR(KBr): 3391, 3184, 2961, 2920, 2850, 1646,1500, 1469, 1423, 1379, 1253, 1060, 970 cm-1; HRMS (ESI) calcd. forC11H14BrNOS2: [M+Na]+:341.9598, found:341.9597.The target product was characterized by NMR as follows: 1H NMR (400 MHz, CDCl3) ppm: 7.64 (s, 1H), 7.46-7.36 (t, J = 15.3, 7.7 Hz, 2H), 7.28-7.20 (t, J = 15.8, 8.0 Hz, 2H), 5.08-4.98 (dd, J = 8.5, 3.2 Hz, 1H), 3.91-3.81 (dd, J = 14.6, 3.4 Hz, 1H), 3.59 (s, 3H), 3.58-3.50 (dd, J = 14.6, 6.0 Hz, 1H), 3.43 (s, 3H), 3.29(s, 1H); 13C NMR (100 MHz, CDCl3) 197.3, 145.2, 130.8, 130.0, 129.0, 124.6,122.6, 72.6 , 45.9, 45.5, 41.8; IR(KBr): 3391, 3184, 2961, 2920, 2850, 1646, 1500, 1469, 1423, 1379, 1253, 1060, 970 cm-1; HRMS (ESI) calcd. forC11H14BrNOS2: [ M+Na]+:341.9598, found:341.9597.
实施例5Example 5
2-(4-氟苯基)-2-羟乙基二甲基氨基二硫代酸酯的制备方法,包括以下步骤:The preparation method of 2-(4-fluorophenyl)-2-hydroxyethyl dimethylamino dithioate comprises the following steps:
(1)取4-氟苯乙烯0.2mmol、二硫化四甲基秋兰姆0.1mmol和乙醇钠0.2mmol,加入1 ml的1.4-二氧六环,得到混合物,将该混合物置于5ml的Schlenk管内,置于80℃的油浴中加热,反应48h后,冷却至室温,得到反应液;(1) Take 0.2 mmol of 4-fluorostyrene, 0.1 mmol of tetramethylthiuram disulfide and 0.2 mmol of sodium ethoxide, add 1 ml of 1.4-dioxane to obtain a mixture, put the mixture in 5 ml of Schlenk In the tube, it was heated in an oil bath at 80°C, and after 48 hours of reaction, it was cooled to room temperature to obtain a reaction solution;
(2)将步骤(1)所得到的反应液直接进行浓缩得浓缩物,将浓缩物以乙酸乙酯/石油醚=1/5(v/v)为展开剂,进行薄层色谱分离,得12.2mg目标产物。(2) The reaction solution obtained in step (1) is directly concentrated to obtain a concentrate, and the concentrate is separated by thin layer chromatography with ethyl acetate/petroleum ether=1/5 (v/v) as a developing solvent to obtain 12.2 mg of the desired product.
本实施例的目标产品收率为47%。The target product yield of this embodiment is 47%.
对目标产品进行核磁表征,如下:1H NMR (400 MHz, CDCl3) ppm: 7.50-7.40(m, 2H), 7.10-7.00 (m, 2H), 5.10-4.98 (dd, J = 8.4, 2.8 Hz, 1H), 3.90-3.78(dd, J = 14.5, 3.4 Hz, 1H), 3.59 (s, 3H), 3.58-3.50 (m, 1H), 3.43 (s, 3H),3.17 (s, 1H); 13C NMR (100 MHz, CDCl3) 197.4, 162.3(d, J = 244.1 Hz), 138.7(d, J = 2.9 Hz), 127.5 (d, J = 8.1 Hz), 115.3 (d, J = 21.2 Hz), 72.7, 45.9,45.8, 41.8; IR(KBr): 3397, 3203, 2920, 2850, 1646, 1508, 1468, 1378, 1254,1224, 1155, 1060, 973, 830 cm-1; HRMS (ESI) calcd. for C11H14FNOS2: [M+Na]+:282.0399, found: 282.0400.The target product was characterized by NMR as follows: 1H NMR (400 MHz, CDCl3) ppm: 7.50-7.40(m, 2H), 7.10-7.00 (m, 2H), 5.10-4.98 (dd, J = 8.4, 2.8 Hz, 1H), 3.90-3.78(dd, J = 14.5, 3.4 Hz, 1H), 3.59 (s, 3H), 3.58-3.50 (m, 1H), 3.43 (s, 3H), 3.17 (s, 1H); 13C NMR (100 MHz, CDCl3) 197.4, 162.3 (d, J = 244.1 Hz), 138.7 (d, J = 2.9 Hz), 127.5 (d, J = 8.1 Hz), 115.3 (d, J = 21.2 Hz), 72.7 HRMS (ESI) calcd. for C11H14FNOS2: [M+Na]+:282.0399, found: 282.0400.
实施例6Example 6
2-(4-甲氧基苯基)-2-羟乙基二甲基氨基二硫代酸酯的制备方法,包括以下步骤:The preparation method of 2-(4-methoxyphenyl)-2-hydroxyethyl dimethylamino dithioate comprises the following steps:
(1)取4-甲氧基苯乙烯0.2mmol、二硫化四甲基秋兰姆0.1mmol和乙醇钠0.2mmol,加入1ml的1.4-二氧六环,得到混合物,将该混合物置于5ml的Schlenk管内,置于80℃的油浴中加热,反应48h后,冷却至室温,得到反应液;(1) Take 0.2 mmol of 4-methoxystyrene, 0.1 mmol of tetramethylthiuram disulfide and 0.2 mmol of sodium ethoxide, add 1 ml of 1.4-dioxane to obtain a mixture, put the mixture in 5 ml of In a Schlenk tube, it was heated in an oil bath at 80°C, and after 48 hours of reaction, it was cooled to room temperature to obtain a reaction solution;
(2)将步骤(1)所得到的反应液直接进行浓缩得浓缩物,将浓缩物以乙酸乙酯/石油醚=1/5(v/v)为展开剂,进行薄层色谱分离,得13.6mg目标产物。(2) The reaction solution obtained in step (1) is directly concentrated to obtain a concentrate, and the concentrate is separated by thin layer chromatography with ethyl acetate/petroleum ether=1/5 (v/v) as a developing solvent to obtain 13.6 mg of the desired product.
本实施例的目标产品收率为50%。The target product yield of this embodiment is 50%.
对目标产品进行核磁表征,如下:1H NMR (400 MHz, CDCl3) ppm: 7.45-7.36(d, J = 8.6 Hz, 2H), 6.95-6.85 (d, J = 8.8 Hz, 2H), 5.05-4.94 (dd, J = 8.7,3.4 Hz, 1H), 3.86-3.77 (m, 4H), 3.67-3.54 (m, 4H), 3.42 (s, 3H), 3.01 (s,1H); 13C NMR (100 MHz, CDCl3) 197.6, 159.3, 135.1, 127.1, 113.9, 72.9, 55.3,45.8, 41.8; IR(KBr): 3389, 2995, 2955, 2920, 2850, 1611, 1511, 1465, 1377,1302, 1249, 1174, 1146, 1032, 976, 833 cm-1; HRMS (ESI) calcd. forC12H17NO2S2: [M+Na]+:294.0598, found: 294.0597.The target product was characterized by NMR as follows: 1H NMR (400 MHz, CDCl3) ppm: 7.45-7.36(d, J = 8.6 Hz, 2H), 6.95-6.85 (d, J = 8.8 Hz, 2H), 5.05-4.94 (dd, J = 8.7, 3.4 Hz, 1H), 3.86-3.77 (m, 4H), 3.67-3.54 (m, 4H), 3.42 (s, 3H), 3.01 (s, 1H); 13C NMR (100 MHz) , CDCl3) 197.6, 159.3, 135.1, 127.1, 113.9, 72.9, 55.3, 45.8, 41.8; IR(KBr): 3389, 2995, 2955, 2920, 2850, 16,11, 1511, 1465, 1377,1 1146, 1032, 976, 833 cm-1; HRMS (ESI) calcd. forC12H17NO2S2: [M+Na]+:294.0598, found: 294.0597.
实施例7Example 7
2-(4-叔丁基苯基)-2-羟乙基二甲基氨基二硫代酸酯的制备方法,包括以下步骤:The preparation method of 2-(4-tert-butylphenyl)-2-hydroxyethyl dimethylamino dithioate comprises the following steps:
(1)取4-叔丁基苯乙烯0.2mmol、二硫化四甲基秋兰姆0.1mmol和乙醇钠0.2mmol,加入1ml的1.4-二氧六环,得到混合物,将该混合物置于5ml的Schlenk管内,置于80 ℃的油浴中加热,反应48 h后,冷却至室温,得到反应液;(1) Take 0.2 mmol of 4-tert-butylstyrene, 0.1 mmol of tetramethylthiuram disulfide and 0.2 mmol of sodium ethoxide, add 1 ml of 1.4-dioxane to obtain a mixture, put the mixture in 5 ml of In a Schlenk tube, it was heated in an oil bath at 80 °C, and after 48 h of reaction, it was cooled to room temperature to obtain a reaction solution;
(2)将步骤(1)所得到的反应液直接进行浓缩得浓缩物,将浓缩物以乙酸乙酯/石油醚=1/5(v/v)为展开剂,进行薄层色谱分离,得14.4mg目标产物。(2) The reaction solution obtained in step (1) is directly concentrated to obtain a concentrate, and the concentrate is separated by thin layer chromatography with ethyl acetate/petroleum ether=1/5 (v/v) as a developing solvent to obtain 14.4 mg of the desired product.
本实施例的目标产品收率为48%。The target product yield of this embodiment is 48%.
对目标产品进行核磁表征,如下:1H NMR (400 MHz, CDCl3) ppm: 7.40 (s,4H), 5.10-4.90 (dd, J = 9.0, 3.3 Hz, 1H), 3.90-3.80 (dd, J = 14.4, 3.4 Hz,1H), 3.70-3.60 (dd, J = 14.4, 9.1 Hz, 1H), 3.59 (s, 3H), 3.42 (s, 3H), 3.02(s, 1H); 13C NMR (100 MHz, CDCl3) 197.6, 150.8, 140.0, 125.6, 125.4, 73.1,45.8, 45.7, 41.8, 34.6, 31.4; IR(KBr): 3415, 2959, 2925, 2867, 1660, 1502,1408, 1375, 1254, 1145, 1108, 1057, 977, 838 cm-1; HRMS (ESI) calcd. forC15H23NOS2: [M+Na]+:320.1119, found: 320.1118.The target product was characterized by NMR as follows: 1H NMR (400 MHz, CDCl3) ppm: 7.40 (s, 4H), 5.10-4.90 (dd, J = 9.0, 3.3 Hz, 1H), 3.90-3.80 (dd, J = 14.4, 3.4 Hz, 1H), 3.70-3.60 (dd, J = 14.4, 9.1 Hz, 1H), 3.59 (s, 3H), 3.42 (s, 3H), 3.02(s, 1H); 13C NMR (100 MHz) , CDCl3) 197.6, 150.8, 140.0, 125.6, 125.4, 73.1, 45.8, 45.7, 41.8, 34.6, 31.4; IR(KBr): 3415, 2959, 2925, 2867, 1660, 1502,124 1,1 1108, 1057, 977, 838 cm-1; HRMS (ESI) calcd. forC15H23NOS2: [M+Na]+:320.1119, found: 320.1118.
实施例8Example 8
2-羟基-2-(4-甲基噻唑-5-基)二甲基氨基甲酸二硫代乙酯的制备方法,包括以下步骤:The preparation method of 2-hydroxy-2-(4-methylthiazol-5-yl) dimethyl carbamate dithioethyl ester comprises the following steps:
(1)取4-甲基-5-乙烯基噻唑0.2mmol、二硫化四甲基秋兰姆0.1mmol和乙醇钠0.2mmol,加入1ml的1.4-二氧六环,得到混合物,将该混合物置于5ml的Schlenk管内,置于80 ℃的油浴中加热,反应48h后,冷却至室温,得到反应液;(1) Take 0.2 mmol of 4-methyl-5-vinylthiazole, 0.1 mmol of tetramethylthiuram disulfide and 0.2 mmol of sodium ethoxide, add 1 ml of 1.4-dioxane to obtain a mixture, put the mixture into In a 5ml Schlenk tube, heat in an oil bath at 80 °C, and after 48 hours of reaction, cool to room temperature to obtain a reaction solution;
(2)将步骤(1)所得到的反应液直接进行浓缩得浓缩物,将浓缩物以乙酸乙酯/石油醚=1/5(v/v)为展开剂,进行薄层色谱分离,得14.9mg目标产物。(2) The reaction solution obtained in step (1) is directly concentrated to obtain a concentrate, and the concentrate is separated by thin layer chromatography with ethyl acetate/petroleum ether=1/5 (v/v) as a developing solvent to obtain 14.9 mg of the desired product.
本实施例的目标产品收率为57%。The target product yield of this embodiment is 57%.
对目标产品进行核磁表征,如下:1H NMR (400 MHz, CDCl3) ppm: 8.66 (s,1H), 5.45-5.35 (dd, J = 7.8, 3.9 Hz, 1H), 3.93-3.82 (dd, J = 14.4, 4.0 Hz,1H), 3.67 (s, 1H), 3.65-3.60 (d, J = 7.9 Hz, 1H), 3.59 (s, 3H), 3.43 (s, 3H),2.49 (s, 3H); 13C NMR (100 MHz, CDCl3) 196.8, 151.0, 148.9, 134.2, 67.1,45.9, 45.1, 41.8, 15.7; IR(KBr): 3361, 3199, 2955, 2922, 2851, 1657, 1502,1468, 1411, 1376, 1254, 1145, 1057, 978, 945 cm-1; HRMS (ESI) calcd. forC9H14N2OS2: [M+Na]+: 285.0166, found: 285.0168.The target product was characterized by NMR as follows: 1H NMR (400 MHz, CDCl3) ppm: 8.66 (s, 1H), 5.45-5.35 (dd, J = 7.8, 3.9 Hz, 1H), 3.93-3.82 (dd, J = 14.4, 4.0 Hz, 1H), 3.67 (s, 1H), 3.65-3.60 (d, J = 7.9 Hz, 1H), 3.59 (s, 3H), 3.43 (s, 3H), 2.49 (s, 3H); 13C NMR (100 MHz, CDCl3) 196.8, 151.0, 148.9, 134.2, 67.1, 45.9, 45.1, 41.8, 15.7; IR(KBr): 3361, 3199, 2955, 2922, 2851, 1657, 1502, 137668, , 1254, 1145, 1057, 978, 945 cm-1; HRMS (ESI) calcd. forC9H14N2OS2: [M+Na]+: 285.0166, found: 285.0168.
实施例9Example 9
2-(4-氯苯基)-2-羟乙基二乙基氨基二硫代酸酯的制备方法,包括以下步骤:The preparation method of 2-(4-chlorophenyl)-2-hydroxyethyl diethyl amino dithioate, comprises the following steps:
(1)取4-氯苯乙烯0.2mmol、二硫化四乙基秋兰姆0.1mmol和乙醇钠0.2mmol,加入1 ml的1.4-二氧六环,得到混合物,将该混合物置于5 ml的Schlenk管内,置于80℃的油浴中加热,反应48h后,冷却至室温,得到反应液;(1) Take 0.2 mmol of 4-chlorostyrene, 0.1 mmol of tetraethylthiuram disulfide and 0.2 mmol of sodium ethoxide, add 1 ml of 1.4-dioxane to obtain a mixture, put the mixture in 5 ml of In a Schlenk tube, it was heated in an oil bath at 80°C, and after 48 hours of reaction, it was cooled to room temperature to obtain a reaction solution;
(2)将步骤(1)所得到的反应液直接进行浓缩得浓缩物,将浓缩物以乙酸乙酯/石油醚=1/5(v/v)为展开剂,进行薄层色谱分离,得12mg目标产物。(2) The reaction solution obtained in step (1) is directly concentrated to obtain a concentrate, and the concentrate is separated by thin layer chromatography with ethyl acetate/petroleum ether=1/5 (v/v) as a developing solvent to obtain 12 mg of the desired product.
本实施例的目标产品收率为40%。The target product yield of this embodiment is 40%.
对目标产品进行核磁表征,如下:1H NMR (400 MHz, CDCl3) ppm: 7.44-7.39(d, J = 8.4 Hz, 2H), 7.36-7.31 (d, J = 8.5Hz, 2H), 5.08-5.01 (dd, J = 8.4,3.4 Hz, 1H), 4.12-3.99 (m, 2H), 3.89-3.81 (dd, J = 14.5, 3.5 Hz, 1H), 3.81-3.74 (m, 2H), 3.60-3.51 (dd, J = 14.5, 8.4Hz, 1H), 3.37 (s, 1H), 1.38-1.23(m, 6H); 13C NMR (100 MHz, CDCl3)195.8, 141.5, 133.4, 128.6, 127.3, 72.7,50.2, 47.1, 45.1, 12.5, 11.6; IR(KBr): 3358, 2977, 2930, 1489, 1458, 1418,1379, 1354, 1299, 1269, 1204, 1090, 1069, 831, 527 cm-1; HRMS (ESI) calcd.for C13H18ClNOS2: [M+Na]+: 324.0416, found: 324.0414.The target product was characterized by NMR as follows: 1H NMR (400 MHz, CDCl3) ppm: 7.44-7.39(d, J = 8.4 Hz, 2H), 7.36-7.31 (d, J = 8.5Hz, 2H), 5.08-5.01 (dd, J = 8.4, 3.4 Hz, 1H), 4.12-3.99 (m, 2H), 3.89-3.81 (dd, J = 14.5, 3.5 Hz, 1H), 3.81-3.74 (m, 2H), 3.60-3.51 (dd, J = 14.5, 8.4Hz, 1H), 3.37 (s, 1H), 1.38-1.23(m, 6H); 13C NMR (100 MHz, CDCl3) 195.8, 141.5, 133.4, 128.6, 127.3, 72.7,50.2 HRMS ( ) calcd.for C13H18ClNOS2: [M+Na]+: 324.0416, found: 324.0414.
实施例10Example 10
2-(3-氯苯基)-2-羟乙基二乙基氨基二硫代酸酯的制备方法,包括以下步骤:The preparation method of 2-(3-chlorophenyl)-2-hydroxyethyl diethyl amino dithioate, comprises the following steps:
(1)取3-氯苯乙烯0.2mmol、二硫化四乙基秋兰姆0.1mmol和乙醇钠0.2mmol,加入1ml的1.4-二氧六环,得到混合物,将该混合物置于5ml的Schlenk管内,置于80℃的油浴中加热,反应48h后,冷却至室温,得到反应液;(1) Take 0.2 mmol of 3-chlorostyrene, 0.1 mmol of tetraethylthiuram disulfide and 0.2 mmol of sodium ethoxide, add 1 ml of 1.4-dioxane to obtain a mixture, and place the mixture in a 5 ml Schlenk tube , heated in an oil bath at 80°C, reacted for 48h, cooled to room temperature to obtain a reaction solution;
(2)将步骤(1)所得到的反应液直接进行浓缩得浓缩物,将浓缩物以乙酸乙酯/石油醚=1/5(v/v)为展开剂,进行薄层色谱分离,得12.4mg目标产物。(2) The reaction solution obtained in step (1) is directly concentrated to obtain a concentrate, and the concentrate is separated by thin layer chromatography with ethyl acetate/petroleum ether=1/5 (v/v) as a developing solvent to obtain 12.4 mg of the desired product.
本实施例的目标产品收率为41%。The target product yield of this embodiment is 41%.
对目标产品进行核磁表征,如下: 1H NMR (400 MHz, CDCl3) ppm: 7.49 (m,1H), 7.39-7.33 (d, J = 7.3Hz, 1H), 7.33-7.29 (d, J = 7.8 Hz, 1H), 7.29-7.23(m, 1H), 5.10-4.99 (dd, J = 8.4, 3.2 Hz, 1H), 4.13-3.98 (m, 2H), 3.93-3.84(dd, J = 14.6, 3.4 Hz, 1H), 3.84-3.73 (m, 2H), 3.63-3.51 (dd, J = 14.6,8.5Hz, 1H), 3.43 (s, 1H), 1.40-1.20 (m, 6H); 13C NMR (100 MHz, CDCl3) 195.7,145.1, 134.4, 129.7, 127.8, 126.1, 124.1, 72.8, 50.2, 47.2, 45.0, 12.5, 11.6;IR(KBr): 3364, 2974, 2921, 2850, 1647, 1489, 1459, 1419, 1379, 1355, 1270,1205, 1070, 983, 789, 689 cm-1; HRMS (ESI) calcd. for C13H18ClNOS2: [M+Na]+:324.0416, found:324.0414.The target product was characterized by NMR as follows: 1H NMR (400 MHz, CDCl3) ppm: 7.49 (m, 1H), 7.39-7.33 (d, J = 7.3Hz, 1H), 7.33-7.29 (d, J = 7.8 Hz , 1H), 7.29-7.23(m, 1H), 5.10-4.99 (dd, J = 8.4, 3.2 Hz, 1H), 4.13-3.98 (m, 2H), 3.93-3.84(dd, J = 14.6, 3.4 Hz , 1H), 3.84-3.73 (m, 2H), 3.63-3.51 (dd, J = 14.6,8.5Hz, 1H), 3.43 (s, 1H), 1.40-1.20 (m, 6H); 13C NMR (100 MHz) , CDCl3) 195.7, 145.1, 134.4, 129.7, 127.8, 126.1, 124.1, 72.8, 50.2, 47.2, 45.0, 12.5, 11.6; IR(KBr): 3364, 21,74, 2921, 2850, 149, 1647, 1379, 1355, 1270,1205, 1070, 983, 789, 689 cm-1; HRMS (ESI) calcd. for C13H18ClNOS2: [M+Na]+:324.0416, found:324.0414.
实施例11Example 11
2-(3-溴苯基)-2-羟乙基二乙基氨基二硫代酸酯的制备方法,包括以下步骤:The preparation method of 2-(3-bromophenyl)-2-hydroxyethyl diethyl amino dithioate, comprises the following steps:
(1)取3-溴苯乙烯0.2mmol、二硫化四乙基秋兰姆0.1mmol和乙醇钠0.2mmol,加入1 ml的1.4-二氧六环,得到混合物,将该混合物置于5ml的Schlenk管内,置于80℃的油浴中加热,反应48h后,冷却至室温,得到反应液;(1) Take 0.2 mmol of 3-bromostyrene, 0.1 mmol of tetraethylthiuram disulfide and 0.2 mmol of sodium ethoxide, add 1 ml of 1.4-dioxane to obtain a mixture, put the mixture in 5 ml of Schlenk In the tube, it was heated in an oil bath at 80°C, and after 48 hours of reaction, it was cooled to room temperature to obtain a reaction solution;
(2)将步骤(1)所得到的反应液直接进行浓缩得浓缩物,将浓缩物以乙酸乙酯/石油醚=1/5(v/v)为展开剂,进行薄层色谱分离,得11mg目标产物。(2) The reaction solution obtained in step (1) is directly concentrated to obtain a concentrate, and the concentrate is separated by thin layer chromatography with ethyl acetate/petroleum ether=1/5 (v/v) as a developing solvent to obtain 11 mg of the desired product.
本实施例的目标产品收率为32%。The target product yield of this embodiment is 32%.
对目标产品进行核磁表征,如下:1H NMR (400 MHz, CDCl3) ppm: 7.64 (s,1H), 7.45-7.36 (m, 2H), 7.29-7.20 (m, 1H), 5.10-4.98 (t, J = 8.4, 4.2 Hz,1H), 4.14-3.97 (m, 2H), 3.92-3.84 (dd, J = 14.6, 3.4 Hz, 1H), 3.84-.3.70 (m,2H), 3.63-3.50 (dd, J = 14.6, 8.4 Hz, 1H), 3.47-3.37 (d, J = 3.6 Hz, 1H),1.36-1.27 (m, 6H); 13C NMR (100 MHz, CDCl3) 195.7, 145.4, 130.8, 130.0,129.0, 124.6, 122.6, 72.7, 50.2, 47.2, 45.0, 12.5, 11.6; IR(KBr): 3394, 2957,2922, 2850, 1645, 1489, 1468, 1419, 1379, 1354, 1269, 1205, 1141, 1067, 982cm-1; HRMS (ESI) calcd. for C13H18BrNOS2: [M+Na]+:369.9911, found: 369.9911.The target product was characterized by NMR as follows: 1H NMR (400 MHz, CDCl3) ppm: 7.64 (s,1H), 7.45-7.36 (m, 2H), 7.29-7.20 (m, 1H), 5.10-4.98 (t, J = 8.4, 4.2 Hz, 1H), 4.14-3.97 (m, 2H), 3.92-3.84 (dd, J = 14.6, 3.4 Hz, 1H), 3.84-.3.70 (m, 2H), 3.63-3.50 (dd , J = 14.6, 8.4 Hz, 1H), 3.47-3.37 (d, J = 3.6 Hz, 1H), 1.36-1.27 (m, 6H); 13C NMR (100 MHz, CDCl3) 195.7, 145.4, 130.8, 130.0, 129.0, 124.6, 122.6, 72.7, 50.2, 47.2, 45.0, 12.5, 11.6; IR(KBr): 3394, 2957,2922, 2850, 1645, 1489, 1468, 1419, 1379, 12054, 1412 , 982cm-1; HRMS (ESI) calcd. for C13H18BrNOS2: [M+Na]+:369.9911, found: 369.9911.
实施例12Example 12
2-(4-氟苯基)-2-羟乙基二乙基氨基二硫代酸酯的制备方法,包括以下步骤:The preparation method of 2-(4-fluorophenyl)-2-hydroxyethyldiethylamino dithioate, comprises the following steps:
(1)取4-氟苯乙烯0.2mmol、二硫化四甲基秋兰姆0.1mmol和乙醇钠0.2mmol,加入1 ml的1.4-二氧六环,得到混合物,将该混合物置于5 ml的Schlenk管内,置于80℃的油浴中加热,反应48h后,冷却至室温,得到反应液;(1) Take 0.2 mmol of 4-fluorostyrene, 0.1 mmol of tetramethylthiuram disulfide and 0.2 mmol of sodium ethoxide, add 1 ml of 1.4-dioxane to obtain a mixture, put the mixture in 5 ml of In a Schlenk tube, it was heated in an oil bath at 80°C, and after 48 hours of reaction, it was cooled to room temperature to obtain a reaction solution;
(2)将步骤(1)所得到的反应液直接进行浓缩得浓缩物,将浓缩物以乙酸乙酯/石油醚=1/5(v/v)为展开剂,进行薄层色谱分离,得8.9mg目标产物。(2) The reaction solution obtained in step (1) is directly concentrated to obtain a concentrate, and the concentrate is separated by thin layer chromatography with ethyl acetate/petroleum ether=1/5 (v/v) as a developing solvent to obtain 8.9 mg of the desired product.
本实施例的目标产品收率为31%。The target product yield of this embodiment is 31%.
对目标产品进行核磁表征,如下:1H NMR (400 MHz, CDCl3) ppm: 7.50-7.40(m, 2H), 7.10-7.00 (t, J = 17.5, 8.8 Hz, 2H), 5.10-4.98 (d, J = 7.7 Hz, 1H),4.15-3.96 (m, 2H), 3.90-3.82 (dd, J = 14.5, 3.5 Hz, 1H), 3.82-3.73 (m,2H),3.64-3.50 (dd, J = 14.5, 8.6 Hz, 1H), 3.31 (s, 1H), 1.37-1.20 (m, 6H); 13CNMR (100 MHz, CDCl3) 195.8, 162.3 (d, J = 244.1 Hz), 138.8 (d, J = 2.3 Hz ),127.6 (d, J = 8.1 Hz), 115.3 (d, J = 21.4 Hz), 72.7, 50.2, 47.1, 45.3, 12.5,11.6; IR(KBr): 3394, 2920, 2848, 1644, 1488, 1467, 1418, 1269, 1207, 1142,1068, 982, 835, 541, 525, 509 cm-1; HRMS (ESI) calcd. for C13H18FNOS2: [M+Na]+: 310.0712, found: 310.0713.The target product was characterized by NMR as follows: 1H NMR (400 MHz, CDCl3) ppm: 7.50-7.40(m, 2H), 7.10-7.00 (t, J = 17.5, 8.8 Hz, 2H), 5.10-4.98 (d, J = 7.7 Hz, 1H), 4.15-3.96 (m, 2H), 3.90-3.82 (dd, J = 14.5, 3.5 Hz, 1H), 3.82-3.73 (m, 2H), 3.64-3.50 (dd, J = 14.5, 8.6 Hz, 1H), 3.31 (s, 1H), 1.37-1.20 (m, 6H); 13CNMR (100 MHz, CDCl3) 195.8, 162.3 (d, J = 244.1 Hz), 138.8 (d, J = 2.3 Hz ), 127.6 (d, J = 8.1 Hz), 115.3 (d, J = 21.4 Hz), 72.7, 50.2, 47.1, 45.3, 12.5, 11.6; IR(KBr): 3394, 2920, 2848, 1644, 1488, 1467, 1418, 1269, 1207, 1142,1068, 982, 835, 541, 525, 509 cm-1; HRMS (ESI) calcd. for C13H18FNOS2: [M+Na]+: 310.0712, found: 310.0713.
实施例13Example 13
2-(4-甲基苯基)-2-羟乙基二乙基氨基二硫代酸酯的制备方法,包括以下步骤:The preparation method of 2-(4-methylphenyl)-2-hydroxyethyl diethyl amino dithioate, comprises the following steps:
(1)取3-溴苯乙烯0.2mmol、二硫化四乙基秋兰姆0.1mmol和乙醇钠0.2mmol,加入1ml的1.4-二氧六环,得到混合物,将该混合物置于5ml的Schlenk管内,置于80℃的油浴中加热,反应48h后,冷却至室温,得到反应液;(1) Take 0.2 mmol of 3-bromostyrene, 0.1 mmol of tetraethylthiuram disulfide and 0.2 mmol of sodium ethoxide, add 1 ml of 1.4-dioxane to obtain a mixture, and place the mixture in a 5 ml Schlenk tube , heated in an oil bath at 80°C, reacted for 48h, cooled to room temperature to obtain a reaction solution;
(2)将步骤(1)所得到的反应液直接进行浓缩得浓缩物,将浓缩物以乙酸乙酯/石油醚=1/5(v/v)为展开剂,进行薄层色谱分离,得7.4mg目标产物。(2) The reaction solution obtained in step (1) is directly concentrated to obtain a concentrate, and the concentrate is separated by thin layer chromatography with ethyl acetate/petroleum ether=1/5 (v/v) as a developing solvent to obtain 7.4 mg of the desired product.
本实施例的目标产品收率为26%。The target product yield of this embodiment is 26%.
对目标产品进行核磁表征,如下:1H NMR (400 MHz, CDCl3) ppm: 7.41-7.33(d, J = 8.0 Hz, 2H), 7.23-7.13 (d, J = 7.9 Hz, 2H), 5.08-4.93 (t, J = 8.6,5.0 Hz, 1H), 4.15-3.95 (m, 2H), 3.89-3.81 (dd, J = 14.4, 3.6 Hz, 1H), 3.81-3.72 (m, 2H), 3.69-3.57 (dd, J = 14.4, 8.7 Hz, 1H), 3.20-3.08 (d, J = 3.5 Hz,1H), 2.40-2.30 (s, 3H), 1.40-1.20 (m, 6H); 13C NMR (100 MHz, CDCl3) 196.0,140.1, 137.4, 129.1, 125.8, 73.2, 50.1, 47.1, 45.3, 21.2, 12.5, 11.6; IR(KBr): 3394, 2977, 2921, 2849, 1646, 1489, 1463, 1419, 1379, 1355, 1268,1205, 1142, 1067, 982, 736 cm-1; HRMS (ESI) calcd. for C14H21NOS2: [M+Na]+:306.0962, found: 306.0963.The target product was characterized by NMR as follows: 1H NMR (400 MHz, CDCl3) ppm: 7.41-7.33(d, J = 8.0 Hz, 2H), 7.23-7.13 (d, J = 7.9 Hz, 2H), 5.08-4.93 (t, J = 8.6, 5.0 Hz, 1H), 4.15-3.95 (m, 2H), 3.89-3.81 (dd, J = 14.4, 3.6 Hz, 1H), 3.81-3.72 (m, 2H), 3.69-3.57 (dd, J = 14.4, 8.7 Hz, 1H), 3.20-3.08 (d, J = 3.5 Hz, 1H), 2.40-2.30 (s, 3H), 1.40-1.20 (m, 6H); 13C NMR (100 MHz) , CDCl3) 196.0, 140.1, 137.4, 129.1, 125.8, 73.2, 50.1, 47.1, 45.3, 21.2, 12.5, 11.6; IR(KBr): 3394, 2977, 29,21, 2849, 1646, 14689, 1355, 1268,1205, 1142, 1067, 982, 736 cm-1; HRMS (ESI) calcd. for C14H21NOS2: [M+Na]+:306.0962, found: 306.0963.
实施例14Example 14
2-(4-氯苯基)-2-羟乙基二丁基氨基二硫代酸酯的制备方法,包括以下步骤:The preparation method of 2-(4-chlorophenyl)-2-hydroxyethyl dibutylamino dithioate, comprises the following steps:
(1)取4-氯苯乙烯0.2mmol、二硫化四丁基秋兰姆0.1mmol和乙醇钠0.2mmol,加入1ml的1.4-二氧六环,得到混合物,将该混合物置于5ml的Schlenk管内,置于80℃的油浴中加热,反应48h后,冷却至室温,得到反应液;(1) Take 0.2 mmol of 4-chlorostyrene, 0.1 mmol of tetrabutylthiuram disulfide and 0.2 mmol of sodium ethoxide, add 1 ml of 1.4-dioxane to obtain a mixture, and place the mixture in a 5 ml Schlenk tube , heated in an oil bath at 80°C, reacted for 48h, cooled to room temperature to obtain a reaction solution;
(2)将步骤(1)所得到的反应液直接进行浓缩得浓缩物,将浓缩物以乙酸乙酯/石油醚=1/5(v/v)为展开剂,进行薄层色谱分离,得15.1mg目标产物。(2) The reaction solution obtained in step (1) is directly concentrated to obtain a concentrate, and the concentrate is separated by thin layer chromatography with ethyl acetate/petroleum ether=1/5 (v/v) as a developing solvent to obtain 15.1 mg of the desired product.
本实施例的目标产品收率为42%。The target product yield of this embodiment is 42%.
对目标产品进行核磁表征,如下:1H NMR (400 MHz, CDCl3) ppm: 7.47-7.37(d, J = 8.4 Hz, 2H), 7.37-7.30 (d, J = 8.5 Hz, 2H), 5.10-4.96 (d, J = 6.7 Hz,1H), 4.07-3.89 (m, 2H), 3.89-3.80 (dd, J = 14.6, 3.4 Hz, 1H), 3.76-3.61 (m,2H), 3.60-3.50 (dd, J = 14.6, 8.5Hz, 1H), 3.37 (s, 1H), 1.80-1.64 (m, 4H),1.45-1.30 (m, 4H), 1.03-0.90 (m, 6H); 13C NMR (100 MHz, CDCl3)196.0, 141.6,133.4, 128.6, 127.3, 72.7, 55.7, 52.9, 45.2, 29.4, 28.4, 20.1, 13.8, 13.7; IR(KBr): 3358, 2958, 2926, 2857, 1488, 1464, 1415, 1369, 1290, 1218, 1185,1091, 1064, 1013, 980, 945, 828, 755 cm-1; HRMS (ESI) calcd. forC17H26ClNOS2: [M+H]+: 360.1223, found: 360.1223.The target product was characterized by NMR as follows: 1H NMR (400 MHz, CDCl3) ppm: 7.47-7.37(d, J = 8.4 Hz, 2H), 7.37-7.30 (d, J = 8.5 Hz, 2H), 5.10-4.96 (d, J = 6.7 Hz, 1H), 4.07-3.89 (m, 2H), 3.89-3.80 (dd, J = 14.6, 3.4 Hz, 1H), 3.76-3.61 (m, 2H), 3.60-3.50 (dd , J = 14.6, 8.5Hz, 1H), 3.37 (s, 1H), 1.80-1.64 (m, 4H), 1.45-1.30 (m, 4H), 1.03-0.90 (m, 6H); 13C NMR (100 MHz) , CDCl3)196.0, 141.6,133.4, 128.6, 127.3, 72.7, 55.7, 52.9, 45.2, 29.4, 28.4, 20.1, 13.8, 13.7; IR(KBr): 3358, 2958, 2926, 2857 1,4 1369, 1290, 1218, 1185,1091, 1064, 1013, 980, 945, 828, 755 cm-1; HRMS (ESI) calcd. forC17H26ClNOS2: [M+H]+: 360.1223, found: 360.1223.
实施例15Example 15
2-(3-氯苯基)-2-羟乙基二丁基氨基二硫代酸酯的制备方法,包括以下步骤:The preparation method of 2-(3-chlorophenyl)-2-hydroxyethyl dibutylamino dithioate, comprises the following steps:
(1)取3-氯苯乙烯0.2mmol、二硫化四丁基秋兰姆0.1mmol和乙醇钠0.2mmol,加入1ml的1.4-二氧六环,得到混合物,将该混合物置于5ml的Schlenk管内,置于80℃的油浴中加热,反应48h后,冷却至室温,得到反应液;(1) Take 0.2 mmol of 3-chlorostyrene, 0.1 mmol of tetrabutylthiuram disulfide and 0.2 mmol of sodium ethoxide, add 1 ml of 1.4-dioxane to obtain a mixture, and place the mixture in a 5 ml Schlenk tube , heated in an oil bath at 80°C, reacted for 48h, cooled to room temperature to obtain a reaction solution;
(2)将步骤(1)所得到的反应液直接进行浓缩得浓缩物,将浓缩物以乙酸乙酯/石油醚=1/5(v/v)为展开剂,进行薄层色谱分离,得16.5mg目标产物。(2) The reaction solution obtained in step (1) is directly concentrated to obtain a concentrate, and the concentrate is separated by thin layer chromatography with ethyl acetate/petroleum ether=1/5 (v/v) as a developing solvent to obtain 16.5 mg of the desired product.
本实施例的目标产品收率为46%。The target product yield of this embodiment is 46%.
对目标产品进行核磁表征,如下:1H NMR (400 MHz, CDCl3) ppm: 7.48 (s,1H), 7.38-7.33 (m, 1H), 7.33-7.28 (m, 1H), 7.28-7.23 (m, 1H), 5.10-4.98 (t, J= 8.3, 4.9 Hz, 1H), 4.04-3.92 (m, 2H), 3.90-3.80 (dd, J = 14.6, 3.4 Hz, 1H),3.75-3.64 (m, 2H), 3.62-3.50 (dd, J = 14.6, 8.4Hz, 1H), 3.46-3.36 (d, J = 3.3Hz, 1H), 1.80-1.66 (m, 4H), 1.45-1.32 (m, 4H), 1.02-0.93 (m, 6H); 13C NMR(100 MHz, CDCl3) 196.0, 145.1, 134.4, 129.7, 127.8, 126.1, 124.1, 72.8, 55.7,52.9, 45.1, 29.4, 28.4, 20.1, 13.8, 13.7; IR(KBr): 3358, 2959, 2927, 2855,1657, 1632, 1597, 1537, 1468, 1415, 1367, 1290, 1217, 1184, 1140, 1095, 1061cm-1; HRMS (ESI) calcd. for C17H26ClNOS2: [M+H]+: 360.1223, found: 360.1221.The NMR characterization of the target product is as follows: 1H NMR (400 MHz, CDCl3) ppm: 7.48 (s, 1H), 7.38-7.33 (m, 1H), 7.33-7.28 (m, 1H), 7.28-7.23 (m, 1H), 5.10-4.98 (t, J= 8.3, 4.9 Hz, 1H), 4.04-3.92 (m, 2H), 3.90-3.80 (dd, J = 14.6, 3.4 Hz, 1H), 3.75-3.64 (m, 2H), 3.62-3.50 (dd, J = 14.6, 8.4Hz, 1H), 3.46-3.36 (d, J = 3.3Hz, 1H), 1.80-1.66 (m, 4H), 1.45-1.32 (m, 4H) , 1.02-0.93 (m, 6H); 13C NMR (100 MHz, CDCl3) 196.0, 145.1, 134.4, 129.7, 127.8, 126.1, 124.1, 72.8, 55.1, 52.9, 45.1, 29.4, 28.4, 3.8.1, 13.8; IR(KBr): 3358, 2959, 2927, 2855, 1657, 1632, 1597, 1537, 1468, 1415, 1367, 1290, 1217, 1184, 1140, 1095, 1061cm-1; [M+H]+: 360.1223, found: 360.1221.
实施例16Example 16
2-(4-溴苯基)-2-羟乙基二丁基氨基二硫代酸酯的制备方法,包括以下步骤:The preparation method of 2-(4-bromophenyl)-2-hydroxyethyl dibutylamino dithioate, comprises the following steps:
(1)取4-溴苯乙烯0.2mol、二硫化四丁基秋兰姆0.1mmol和乙醇钠0.2mmol,加入1ml的1.4-二氧六环,得到混合物,将该混合物置于5ml的Schlenk管内,置于80℃的油浴中加热,反应48h后,冷却至室温,得到反应液;(1) Take 0.2 mol of 4-bromostyrene, 0.1 mmol of tetrabutylthiuram disulfide and 0.2 mmol of sodium ethoxide, add 1 ml of 1.4-dioxane to obtain a mixture, and place the mixture in a 5 ml Schlenk tube , heated in an oil bath at 80°C, reacted for 48h, cooled to room temperature to obtain a reaction solution;
(2)将步骤(1)所得到的反应液直接进行浓缩得浓缩物,将浓缩物以乙酸乙酯/石油醚=1/5 (v/v)为展开剂,进行薄层色谱分离,得 15.1mg目标产物。(2) The reaction solution obtained in step (1) is directly concentrated to obtain a concentrate, and the concentrate is separated by thin layer chromatography with ethyl acetate/petroleum ether=1/5 (v/v) as a developing solvent to obtain 15.1 mg of the desired product.
本实施例的目标产品收率为38%。The target product yield of this embodiment is 38%.
对目标产品进行核磁表征,如下: 1H NMR (400 MHz, CDCl3) ppm: 7.55-7.45(d, J = 8.4 Hz, 2H), 7.40-7.30 (d, J = 8.4 Hz, 2H), 5.08-4.98 (dd, J = 8.4,3.2 Hz, 1H), 4.06-3.90 (m, 2H), 3.89-3.80 (dd, J = 14.6, 3.4 Hz, 1H), 3.78-3.62 (m, 2H), 3.60-3.50 (dd, J = 14.6, 8.5 Hz, 1H), 3.38 (s, 1H), 1.80-1.66(m, 4H), 1.44-1.30 (m, 4H), 1.03-0.90 (m, 6H); 13C NMR (100 MHz, CDCl3)196.0, 142.0, 131.5, 127.7, 121.5, 72.8, 55.7, 52.9, 45.1, 29.4, 28.4, 20.1,13.8, 13.7; IR(KBr): 3360, 2958, 2928, 2869, 1485, 1414, 1368, 1290, 1250,1218, 1069, 1010, 521 cm-1; HRMS (ESI) calcd. for C17H26BrNOS2: [M+Na]+:426.0537, found: 426.0535.The target product was characterized by NMR as follows: 1H NMR (400 MHz, CDCl3) ppm: 7.55-7.45(d, J = 8.4 Hz, 2H), 7.40-7.30 (d, J = 8.4 Hz, 2H), 5.08-4.98 (dd, J = 8.4, 3.2 Hz, 1H), 4.06-3.90 (m, 2H), 3.89-3.80 (dd, J = 14.6, 3.4 Hz, 1H), 3.78-3.62 (m, 2H), 3.60-3.50 (dd, J = 14.6, 8.5 Hz, 1H), 3.38 (s, 1H), 1.80-1.66(m, 4H), 1.44-1.30 (m, 4H), 1.03-0.90 (m, 6H); 13C NMR ( 100 MHz, CDCl3)196.0, 142.0, 131.5, 127.7, 121.5, 72.8, 55.7, 52.9, 45.1, 29.4, 28.4, 20.1,13.8, 13.7; IR(KBr,): 3360, 2958, 2928, 1486 1368, 1290, 1250,1218, 1069, 1010, 521 cm-1; HRMS (ESI) calcd. for C17H26BrNOS2: [M+Na]+:426.0537, found: 426.0535.
实施例17Example 17
2-(3-溴苯基)-2-羟乙基二丁基氨基二硫代酸酯的制备方法,包括以下步骤:The preparation method of 2-(3-bromophenyl)-2-hydroxyethyl dibutylamino dithioate, comprises the following steps:
(1)取3-溴苯乙烯0.2mmol、二硫化四丁基秋兰姆0.1mmol和乙醇钠0.2mmol,加入1ml的1.4-二氧六环,得到混合物,将该混合物置于5ml的Schlenk管内,置于80℃的油浴中加热,反应48h后,冷却至室温,得到反应液;(1) Take 0.2 mmol of 3-bromostyrene, 0.1 mmol of tetrabutylthiuram disulfide and 0.2 mmol of sodium ethoxide, add 1 ml of 1.4-dioxane to obtain a mixture, and place the mixture in a 5 ml Schlenk tube , heated in an oil bath at 80°C, reacted for 48h, cooled to room temperature to obtain a reaction solution;
(2)将步骤(1)所得到的反应液直接进行浓缩得浓缩物,将浓缩物以乙酸乙酯/石油醚=1/5(v/v)为展开剂,进行薄层色谱分离,得17.6mg目标产物。(2) The reaction solution obtained in step (1) is directly concentrated to obtain a concentrate, and the concentrate is separated by thin layer chromatography with ethyl acetate/petroleum ether=1/5 (v/v) as a developing solvent to obtain 17.6 mg of the desired product.
本实施例的目标产品收率为44%。The target product yield of this embodiment is 44%.
对目标产品进行核磁表征,如下:1H NMR (400 MHz, CDCl3) ppm: 7.64 (s,1H), 7.46-7.36 (t, J = 16.1, 8.1 Hz, 2H), 7.27-7.18 (m, 1H), 5.08-4.98 (d, J= 8.2 Hz, 1H), 4.07-3.90 (m, 2H), 3.90-3.81 (dd, J = 14.6, 3.4 Hz, 1H), 3.78-3.61 (m, 2H), 3.61-3.50 (dd, J = 14.6, 8.4 Hz, 1H), 3.49-3.40 (d, J = 2.8 Hz,1H), 1.80-1.66 (m, 4H), 1.44-1.30 (m, 4H), 1.03-0.90 (m, 6H); 13C NMR (100MHz, CDCl3) 196.0, 145.4, 130.7, 130.0, 129.1, 124.6, 122.6, 72.7, 55.7,52.9, 45.0, 29.4, 28.4, 20.1, 13.8, 13.7; IR(KBr): 3394, 2957, 2923, 2851,1645, 1484, 1417, 1369, 1291, 1251, 1217, 1186, 1093, 1063 cm-1; HRMS (ESI)calcd. for C17H26BrNOS2: [M+Na]+:426.0537, found: 426.0536.The target product was characterized by NMR as follows: 1H NMR (400 MHz, CDCl3) ppm: 7.64 (s, 1H), 7.46-7.36 (t, J = 16.1, 8.1 Hz, 2H), 7.27-7.18 (m, 1H) , 5.08-4.98 (d, J= 8.2 Hz, 1H), 4.07-3.90 (m, 2H), 3.90-3.81 (dd, J = 14.6, 3.4 Hz, 1H), 3.78-3.61 (m, 2H), 3.61 -3.50 (dd, J = 14.6, 8.4 Hz, 1H), 3.49-3.40 (d, J = 2.8 Hz, 1H), 1.80-1.66 (m, 4H), 1.44-1.30 (m, 4H), 1.03-0.90 (m, 6H); 13C NMR (100MHz, CDCl3) 196.0, 145.4, 130.7, 130.0, 129.1, 124.6, 122.6, 72.7, 55.7, 52.9, 45.0, 29.4, 28.4, 20.1, 13.8, 13.7; IR(KBr): 3394, 2957, 2923, 2851,1645, 1484, 1417, 1369, 1291, 1251, 1217, 1186, 1093, 1063 cm-1; HRMS (ESI)calcd. : 426.0536.
实施例18Example 18
2-(4-氟苯基)-2-羟乙基二丁基氨基二硫代酸酯的制备方法,包括以下步骤:The preparation method of 2-(4-fluorophenyl)-2-hydroxyethyldibutylamino dithioester, comprises the following steps:
(1)取4-氟苯乙烯0.2mmol、二硫化四丁基秋兰姆0.1mmol和乙醇钠0.2mmol,加入1ml的1.4-二氧六环得到,混合物,将该混合物置于5ml的Schlenk管内,置于80℃的油浴中加热,反应48h后,冷却至室温,得到反应液;(1) Take 0.2 mmol of 4-fluorostyrene, 0.1 mmol of tetrabutylthiuram disulfide and 0.2 mmol of sodium ethoxide, add 1 ml of 1.4-dioxane to obtain a mixture, and place the mixture in a 5 ml Schlenk tube , heated in an oil bath at 80°C, reacted for 48h, cooled to room temperature to obtain a reaction solution;
(2)将步骤(1)所得到的反应液直接进行浓缩得浓缩物,将浓缩物以乙酸乙酯/石油醚=1/5(v/v)为展开剂,进行薄层色谱分离,得14.6mg目标产物。(2) The reaction solution obtained in step (1) is directly concentrated to obtain a concentrate, and the concentrate is separated by thin layer chromatography with ethyl acetate/petroleum ether=1/5 (v/v) as a developing solvent to obtain 14.6 mg of the desired product.
本实施例的目标产品收率为43%。The target product yield of this embodiment is 43%.
对目标产品进行核磁表征,如下: 1H NMR (400 MHz, CDCl3) ppm: 7.51-7.41(m, 2H), 7.13-6.99 (t, J = 17.4, 8.7 Hz, 2H), 5.10-4.98 (dd, J = 8.5, 3.3 Hz,1H), 4.06-3.88 (m, 2H), 3.88-3.78 (dd, J = 14.5, 3.4 Hz, 1H), 3.78-3.62 (m,2H), 3.62-3.50 (dd, J = 14.5, 8.6 Hz, 1H), 3.33 (s, 1H), 1.80-1.66 (m, 4H),1.45-1.31 (m, 4H), 1.04-0.90 (m, 6H); 13C NMR (100 MHz, CDCl3) 196.0, 162.3(d, J = 244.1 Hz), 138.8 (d, J = 3.0 Hz ), 127.6 (d, J = 8.1 Hz), 115.2 (d, J= 21.4 Hz), 72.8, 55.7, 52.9, 45.3, 29.4, 28.4, 20.1, 13.8, 13.7; IR(KBr):3360, 2958, 2923, 2852, 1509, 1485, 1467, 1415, 1369, 1290, 1221, 1186, 837cm-1; HRMS (ESI) calcd. for C17H26FNOS2: [M+Na]+: 366.1338, found: 366.1339.The target product was characterized by NMR as follows: 1H NMR (400 MHz, CDCl3) ppm: 7.51-7.41(m, 2H), 7.13-6.99 (t, J = 17.4, 8.7 Hz, 2H), 5.10-4.98 (dd, J = 8.5, 3.3 Hz, 1H), 4.06-3.88 (m, 2H), 3.88-3.78 (dd, J = 14.5, 3.4 Hz, 1H), 3.78-3.62 (m, 2H), 3.62-3.50 (dd, J = 14.5, 8.6 Hz, 1H), 3.33 (s, 1H), 1.80-1.66 (m, 4H), 1.45-1.31 (m, 4H), 1.04-0.90 (m, 6H); 13C NMR (100 MHz, CDCl3) 196.0, 162.3 (d, J = 244.1 Hz), 138.8 (d, J = 3.0 Hz ), 127.6 (d, J = 8.1 Hz), 115.2 (d, J = 21.4 Hz), 72.8, 55.7, 52.9, 45.3, 29.4, 28.4, 20.1, 13.8, 13.7; IR(KBr): 3360, 2958, 2923, 2852, 1509, 1485, 1467, 1415, 1369, 1290, 1221, 1186, 837cm-1; HRMS (ESI calc) . for C17H26FNOS2: [M+Na]+: 366.1338, found: 366.1339.
实施例19Example 19
2-羟基-2-苯基乙基二甲基氨基甲二硫代酸酯的制备方法,包括以下步骤:The preparation method of 2-hydroxy-2-phenylethyl dimethylamino methyl dithioate, comprises the following steps:
(1)取苯乙烯0.2mmol、二硫化四丁基秋兰姆0.1mmol和乙醇钠0.2mmol,加入1ml的1.4-二氧六环,得到混合物,将该混合物置于5ml的Schlenk管内,置于80 ℃的油浴中加热,反应48 h后,冷却至室温,得到反应液;(1) Take 0.2 mmol of styrene, 0.1 mmol of tetrabutylthiuram disulfide and 0.2 mmol of sodium ethoxide, add 1 ml of 1.4-dioxane to obtain a mixture, place the mixture in a 5 ml Schlenk tube, and place it in a 5 ml Schlenk tube. Heating in an oil bath at 80 °C, reacting for 48 h, and cooling to room temperature to obtain a reaction solution;
(2)将步骤(1)所得到的反应液直接进行浓缩得浓缩物,将浓缩物以乙酸乙酯/石油醚=1/5(v/v)为展开剂,进行薄层色谱分离,得15.6mg目标产物。(2) The reaction solution obtained in step (1) is directly concentrated to obtain a concentrate, and the concentrate is separated by thin layer chromatography with ethyl acetate/petroleum ether=1/5 (v/v) as a developing solvent to obtain 15.6 mg of the desired product.
本实施例的目标产品收率为23%。The target product yield of this embodiment is 23%.
对目标产品进行核磁表征,如下: 1H NMR (400 MHz, CDCl3) ppm: δ 7.53-7.46(d, J = 7.36 Hz, 2H), 7.42-7.34 (t, J = 14.9, 7.2 Hz, 2H), 7.33-7.27 (t, J =14.6, 7.3 Hz, 1H), 5.10-4.98 (d, J = 8.6 Hz, 1H), 3.92-3.80 (dd, J = 14.5,3.4 Hz, 1H), 3.67-3.60 (t, J = 14.7, 8.8 Hz, 1H), 3.59 (s, 1H), 3.42 (s, 1H),3.15 (s, 1H); 13C NMR (100 MHz, CDCl3)197.6, 142.9, 128.5, 127.8, 125.9,73.3, 45.9, 45.7, 41.8; IR (KBr): 3204, 3028, 2921, 1491, 1451, 1373, 1254,1079, 974, 724, 692 cm-1; HRMS (ESI) calcd. for C11H15NOS2: [M+Na]+:246.0493, found:264.0485.The target product was characterized by NMR as follows: 1H NMR (400 MHz, CDCl3) ppm: δ 7.53-7.46(d, J = 7.36 Hz, 2H), 7.42-7.34 (t, J = 14.9, 7.2 Hz, 2H), 7.33-7.27 (t, J =14.6, 7.3 Hz, 1H), 5.10-4.98 (d, J = 8.6 Hz, 1H), 3.92-3.80 (dd, J = 14.5,3.4 Hz, 1H), 3.67-3.60 ( t, J = 14.7, 8.8 Hz, 1H), 3.59 (s, 1H), 3.42 (s, 1H), 3.15 (s, 1H); 13C NMR (100 MHz, CDCl3) 197.6, 142.9, 128.5, 127.8, 125.9 ,73.3, 45.9, 45.7, 41.8; IR (KBr): 3204, 3028, 2921, 1491, 1451, 1373, 1254, 1079, 974, 724, 692 cm-1; HRMS (ESI) calcd. for C11H15NOS2: [M +Na]+:246.0493, found:264.0485.
上述实施例中1.4-二氧六环为有机溶剂。在其它实施例中,1.4-二氧六环也可用甲苯、二甲苯、均三甲苯、四氢呋喃、乙腈、乙醇和叔丁基甲基醚中的一种或几种来替换;当然,所述有机溶剂也可为1.4-二氧六环与甲苯、二甲苯、均三甲苯、四氢呋喃、乙腈、乙醇、叔丁基甲基醚中的任意一项或几项的组合。In the above embodiment, 1.4-dioxane is an organic solvent. In other embodiments, 1.4-dioxane can also be replaced by one or more of toluene, xylene, mesitylene, tetrahydrofuran, acetonitrile, ethanol and tert-butyl methyl ether; of course, the organic solvent is also It can be any one or a combination of 1.4-dioxane and toluene, xylene, mesitylene, tetrahydrofuran, acetonitrile, ethanol, and tert-butyl methyl ether.
上述实施例中,乙醇钠为碱催化剂。在其它实施例中,所述乙醇钠也可用碳酸铯、碳酸钠、碳酸钾、碳酸氢钾、磷酸钾、碳酸氢钠、醋酸钾、醋酸钠、甲醇锂、叔丁醇锂、叔丁醇钾、叔丁醇钠、氢氧化锂、氢氧化钠、氢氧化钾中的一种或几种来替换;当然,碱催化剂也可为乙醇钠与碳酸铯、碳酸钠、碳酸钾、碳酸氢钾、磷酸钾、碳酸氢钠、醋酸钾、醋酸钠、甲醇锂、叔丁醇锂、叔丁醇钾、叔丁醇钠、氢氧化锂、氢氧化钠、氢氧化钾中的任意一项或几项的组合。In the above embodiment, sodium ethoxide is an alkali catalyst. In other embodiments, the sodium ethoxide can also be cesium carbonate, sodium carbonate, potassium carbonate, potassium bicarbonate, potassium phosphate, sodium bicarbonate, potassium acetate, sodium acetate, lithium methoxide, lithium tert-butoxide, potassium tert-butoxide , one or more of sodium tert-butoxide, lithium hydroxide, sodium hydroxide, potassium hydroxide to replace; of course, the base catalyst can also be sodium ethoxide and cesium carbonate, sodium carbonate, potassium carbonate, potassium bicarbonate, Any one or more of potassium phosphate, sodium bicarbonate, potassium acetate, sodium acetate, lithium methoxide, lithium tert-butoxide, potassium tert-butoxide, sodium tert-butoxide, lithium hydroxide, sodium hydroxide, potassium hydroxide The combination.
上述实施例中,苯乙烯、3-氯苯乙烯、4-氯苯乙烯、3-溴苯乙烯、4-溴苯乙烯、4-氟苯乙烯、4-甲氧基苯乙烯、4-叔丁基苯乙烯、4-甲基-5-乙烯基噻唑为苯乙烯衍生物。其它实施例中,所述苯乙烯衍生物还可为4-甲基苯乙烯。In the above embodiment, styrene, 3-chlorostyrene, 4-chlorostyrene, 3-bromostyrene, 4-bromostyrene, 4-fluorostyrene, 4-methoxystyrene, 4-tert-butyl Styrene and 4-methyl-5-vinylthiazole are styrene derivatives. In other embodiments, the styrene derivative may also be 4-methylstyrene.
上面结合实施例对本发明作了详细的说明,但是,所属技术领域的技术人员能够理解,在不脱离本发明宗旨的前提下,还可以对上述实施例中的各个具体参数进行变更,形成多个具体的实施例,均为本发明的常见变化范围,在此不再一一详述。The present invention has been described in detail above in conjunction with the embodiments, but those skilled in the art can understand that, without departing from the purpose of the present invention, each specific parameter in the above-mentioned embodiments can also be changed to form a plurality of The specific embodiments are all within the common variation range of the present invention, and will not be described in detail here.
Claims (9)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010382653.6A CN111499551A (en) | 2020-05-08 | 2020-05-08 | Preparation method of β-hydroxyl-substituted alkyl dithiocarbamate |
| CN202110496676.4A CN113480460B (en) | 2020-05-08 | 2021-05-07 | Preparation method of beta-hydroxy substituted alkyl dithiocarbamate |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010382653.6A CN111499551A (en) | 2020-05-08 | 2020-05-08 | Preparation method of β-hydroxyl-substituted alkyl dithiocarbamate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111499551A true CN111499551A (en) | 2020-08-07 |
Family
ID=71869816
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010382653.6A Withdrawn CN111499551A (en) | 2020-05-08 | 2020-05-08 | Preparation method of β-hydroxyl-substituted alkyl dithiocarbamate |
| CN202110496676.4A Expired - Fee Related CN113480460B (en) | 2020-05-08 | 2021-05-07 | Preparation method of beta-hydroxy substituted alkyl dithiocarbamate |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110496676.4A Expired - Fee Related CN113480460B (en) | 2020-05-08 | 2021-05-07 | Preparation method of beta-hydroxy substituted alkyl dithiocarbamate |
Country Status (1)
| Country | Link |
|---|---|
| CN (2) | CN111499551A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113264861A (en) * | 2021-06-02 | 2021-08-17 | 河南农业大学 | Preparation method of alkyl dithiocarbamate |
| CN113480460A (en) * | 2020-05-08 | 2021-10-08 | 河南农业大学 | Preparation method of beta-hydroxy substituted alkyl dithiocarbamate |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108794426A (en) * | 2018-08-02 | 2018-11-13 | 河南农业大学 | A kind of heterocycle dithio carbamate compounds and preparation method thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3105622C2 (en) * | 1981-02-16 | 1986-06-05 | Akzo Gmbh, 5600 Wuppertal | Process for the production of thiuram disulfides |
| FR2884517B1 (en) * | 2005-04-19 | 2007-05-25 | Arkema Sa | PROCESS FOR THE PREPARATION OF ALCOXAMINES BY PHOTOLYSIS OF DITHIOCARBAMATES |
| WO2009111725A1 (en) * | 2008-03-07 | 2009-09-11 | Carnegie Mellon University | Improved controlled radical polymerization processes |
| CN104350039B (en) * | 2012-04-20 | 2017-10-03 | 组合化学工业株式会社 | Alkylphenyl sulfide derivatives and pest control agents |
| CN111499551A (en) * | 2020-05-08 | 2020-08-07 | 河南农业大学 | Preparation method of β-hydroxyl-substituted alkyl dithiocarbamate |
-
2020
- 2020-05-08 CN CN202010382653.6A patent/CN111499551A/en not_active Withdrawn
-
2021
- 2021-05-07 CN CN202110496676.4A patent/CN113480460B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108794426A (en) * | 2018-08-02 | 2018-11-13 | 河南农业大学 | A kind of heterocycle dithio carbamate compounds and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| BANG-QING NI 等: "Molecular Iodine Catalyzed Hydroxysulfenylation of Alkenes with Disulfides in Aerobic Conditions", 《SYNLETT》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113480460A (en) * | 2020-05-08 | 2021-10-08 | 河南农业大学 | Preparation method of beta-hydroxy substituted alkyl dithiocarbamate |
| CN113264861A (en) * | 2021-06-02 | 2021-08-17 | 河南农业大学 | Preparation method of alkyl dithiocarbamate |
Also Published As
| Publication number | Publication date |
|---|---|
| CN113480460B (en) | 2023-04-07 |
| CN113480460A (en) | 2021-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10457698B2 (en) | Chiral reagents for preparation of substituted phosphorodiamidate morpholino oligomers | |
| CN113480460B (en) | Preparation method of beta-hydroxy substituted alkyl dithiocarbamate | |
| CN110099910B (en) | Preparation method and co-crystal of 7H-pyrrolo[2,3-d]pyrimidine derivatives | |
| CN106977415A (en) | One planting sand storehouse must be bent intermediate and preparation method thereof | |
| CN104292255A (en) | Preparation method of S-aryl phosphorothioate | |
| WO2020043033A2 (en) | Synthesis methods for upadacitinib and intermediate thereof | |
| GB2144418A (en) | Thiazolinoazetidinone derivatives and process for the preparation of the same | |
| JP2021517903A (en) | Hexahydrofluorofuranol derivative preparation method, hexahydroflufuranol derivative intermediate, and its preparation method | |
| WO2019174176A1 (en) | Preparation method for hexahydrofuro-furan-ol derivative and intermediate of derivative and preparation method therefor | |
| CN102939285B (en) | Preparation method of 5-[[2(r)-[1(r)-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(s)-4-fluorophenyl-4-morpholinyl]methyl]-1,2-dihydro-3h-1,2,4-triazole-3-one | |
| CN113264861B (en) | Preparation method of alkyl dithiocarbamate | |
| WO2017109524A1 (en) | Method and intermediate for the production of baricitinib | |
| CN1321975C (en) | Diethyl 4[(4-oxo-3-bromo) butyl] benzoyl-L-glutamate and preparation and use | |
| CN102796107B (en) | A kind of method of synthesis pyrroles [2,3-b] Benzazole compounds | |
| CN109053631B (en) | Synthetic method for synthesizing benzo [1,3] oxazine-2-thioketone through isothiocyanate and 2-sulfonyl alkyl phenol | |
| CN101500992A (en) | Process for preparing intermediates for the preparation of 1-methylcarbapenem | |
| JPS61243088A (en) | Heterocyclyl-penem compound | |
| CN111253405B (en) | Preparation method of biapenem intermediate | |
| JPH0334982A (en) | Reduction of cephalosporin | |
| CN107325020A (en) | The preparation method of Ao Gelieting intermediates | |
| CN103012232B (en) | Method for preparing 3-halogenation-2,5-pyrroline compound | |
| CN101177416B (en) | (2'S,3'R,4S)-3-[2'-(N-substituted aminomethyl)-3'-hydroxy butyryl]-4-substituted oxazolidin-2-ketone derivative and preparation method thereof | |
| CN118284609A (en) | Method for preparing triazolopyrimidinone derivatives | |
| HK40069732B (en) | A substantially diastereomerically pure phosphoramidochloridate, a method and a pharmaceutical composition | |
| JPH0219832B2 (en) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20200807 |